IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000104 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
215,267
Total Value
$10,553,746.47
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Sale | 20,000 | $82.60 | $1,651,980.00 | 80,293 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Exercise/Conversion | 48,626 | $60.89 | $2,960,837.14 | 128,919 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Sale | 48,626 | $83.03 | $4,037,338.98 | 80,293 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Exercise/Conversion | 16,463 | $32.60 | $536,693.80 | 96,756 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 2, 2026 | Sale | 16,463 | $83.03 | $1,366,896.55 | 80,293 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | Derivative | Feb 2, 2026 | Exercise/Conversion | 16,463 | $0.00 | $0.00 | 2,406 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Non-Qualified Stock Option (right to buy) | Derivative | Feb 2, 2026 | Exercise/Conversion | 48,626 | $0.00 | $0.00 | 0 | Direct | โ | View Details |